Role of plasma N-terminal proB-type natriuretic peptide (NT-proBNP) level in acute cardioembolic stroke

Mukoyama, 1991, Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide, J Clin Invest, 87, 1402, 10.1172/JCI115146 Valli, 1999, Review of 10 years of the clinical use of brain natriuretic peptide in cardiology, J Lab Clin Med, 134, 437, 10.1016/S0022-2143(99)90163-4 Mukoyama, 1990, Increased human brain natriuretic peptide in congestive heart failure, N Engl J Med., 323, 757, 10.1056/NEJM199009133231114 Yasue, 1994, Localization and mechanism of secretion of B type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure, Circulation, 90, 195, 10.1161/01.CIR.90.1.195 Richards, 1998, Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction, Circulation, 97, 1921, 10.1161/01.CIR.97.19.1921 Groenning, 2001, Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohormonal plasma concentrations, Eur J Heart Fail, 3, 699, 10.1016/S1388-9842(01)00181-7 James, 2003, N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: GUSTO-IV substudy, Circulation, 108, 275, 10.1161/01.CIR.0000079170.10579.DC Wu, 2006, N terminal pro-brain natriuretic peptide is a biomarker of congestive heart failure and predictive of 30-day untoward clinical outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention, Circ J, 70, 163, 10.1253/circj.70.163 de Lemos, 2001, The prognostic value of B-type brain natriuretic peptide in patients with acute coronary syndromes, N Engl J Med, 345, 1014, 10.1056/NEJMoa011053 Lynch, 2004, Novel diagnostic test for acute stroke, Stroke, 35, 57, 10.1161/01.STR.0000105927.62344.4C Nakagawa, 2005, Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke, Cerebrovasc Dis, 19, 157, 10.1159/000083249 Cakir, 2010, A prospective study of brain natriuretic peptide levels in three subgroups: stroke with hypertension, stroke without hypertension, and hypertension alone, Ann Indian Acad Neurol, 13, 47, 10.4103/0972-2327.61277 Di Angelantonio, 2007, Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA, J Neurol Sci, 260, 139, 10.1016/j.jns.2007.04.018 Makikallio, 2005, Natriuretic peptides and mortality after stroke, Stroke, 36, 1016, 10.1161/01.STR.0000162751.54349.ae Shibazaki, 2009, Plasma brain natriuretic peptide as an independent predictor of in-hospital mortality after acute ischemic stroke, Intern Med, 48, 1601, 10.2169/internalmedicine.48.2166 Adams, 1993, Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment, Stroke, 24, 35, 10.1161/01.STR.24.1.35 Myers, 1982, Cardiac sequelae of acute stroke, Stroke, 13, 838, 10.1161/01.STR.13.6.838 Levin, 1998, Natriuretic peptides, N Engl J Med, 339, 321, 10.1056/NEJM199807303390507 Schwarz, 2003, Neuroendocrine changes in patients with acute space occupying ischaemic stroke, J Neurol Neurosurg Psychiatr, 74, 725, 10.1136/jnnp.74.6.725 Fassbender, 1994, Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome, Stroke, 25, 1105, 10.1161/01.STR.25.6.1105 Fujishima, 1996, Serial changes in blood pressure and neurohormone levels after the onset of lacunar stroke, Angiology, 47, 579, 10.1177/000331979604700606 Myers, 1981, Plasma norepinephrine in stroke, Stroke, 12, 200, 10.1161/01.STR.12.2.200 Koenig, 2007, B-type natriuretic peptide as a marker for heart failure in patients with acute stroke, Intensive Care Med, 33, 1587, 10.1007/s00134-007-0704-1 Clerico, 2011, Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones, Am J Physiol Heart Circ Physiol, 301, H12, 10.1152/ajpheart.00226.2011 Shi, 2009, Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke, Curr Med Chem, 16, 4593, 10.2174/092986709789760779 Weidemann, 2008, Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction, Biochem J, 409, 233, 10.1042/BJ20070629 Grau, 2001, Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank, Stroke, 32, 2559, 10.1161/hs1101.098524 Adams, 1993, Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment, Stroke, 24, 35, 10.1161/01.STR.24.1.35 Ageno, 2002, Plasma measurement of d-dimer levels for the early diagnosis of ischemic stroke subtypes, Arch Intern Med, 162, 2589, 10.1001/archinte.162.22.2589 Ladenvall, 2006, Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype, Stroke, 37, 2018, 10.1161/01.STR.0000231872.86071.68 Giannakoulas, 2005, N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke, Angiology, 56, 723, 10.1177/000331970505600610 Sharma, 2006, N-terminal proBrain natriuretic peptide levels predict short-term poststroke survival, J Stroke Cerebrovasc Dis, 15, 121, 10.1016/j.jstrokecerebrovasdis.2006.03.003 Fonseca, 2011, N-terminal probrain natriuretic peptide as a biomarker of cardioembolic stroke, Int J Stroke, 6, 398, 10.1111/j.1747-4949.2011.00606.x Rodríguez-Yáñez, 2009, High serum levels of pro-brain natriuretic peptide (pro BNP) identify cardioembolic origin in undetermined stroke, Dis Markers, 26, 189, 10.1155/2009/351591